Novartis drug may help older breast cancer patients (Reuters)
Reuters – Novartis’s bone drug Zometa extended survival in older breast cancer patients but failed to improve disease-free survival among younger women patients in a large-scale clinical trial, researchers said on Sunday.
View full post on Yahoo! News: Health News
Leave a Reply